"Having a sugar-free, bioequivalent to Bromfed DM® Cough Syrup supports our strategy of providing pharmaceutical drugs to all of our customers," said Allen Fields, Acella Senior VP, Clinical and Regulatory Affairs, Head of Research and Development. "We are excited about our other, affordable products currently under review with the U.S. Food and Drug Administration, in fulfilment of our mission to patients and managed care."
* Except for Acella's product, all other product names, logos, trademarks, and brands referenced in this material are the property of their respective owners, and for identification purposes only. Except as expressly stated, the use of any other product name, logo, trademark or brand does not mean or imply association with, or endorsement by the holder of, that other product name, logo, trademark or brand.
About Acella Pharmaceuticals, LLC
Founded in 2007, Acella Pharmaceuticals is a specialty pharmaceutical company committed to accelerating the health care solution by bringing quality, affordable products to customers and patients. Acella develops, markets, sells and distributes a broad portfolio of non-branded pharmaceutical products in the areas of Dermatology, Women's Health, Pediatrics and other applications. For additional information please contact Acella at 678-325-5189 or visit www.acellapharma.com.
Logo - http://photos.prnewswire.com/prnh/20160407/352847LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/acella-pharmaceuticals-llc-announces-approval-of-a-generic-bromfed-antihistaminedecongestant-300353336.html
SOURCE Acella Pharmaceuticals, LLC